Toes-Zoutendijk E. Interval cancers after a negative faecal immunochemical test in the first screening round in the Netherlands: results for two cut-off levels. UEG Week 2018, LB14.
Effectiviteit en veiligheid van zenocutuzumab bij NRG1-fusiepositieve tumoren
mei 2025 | Longoncologie, Maag-darm-leveroncologie